Identity
- Trade Name
- SPECIFIC PROTEIN CONTROL - LEVEL 3 (SP CONTROL 3) FDA UDI
- Generic Name
- Multiple clinical chemistry protein IVD, control FDA UDI
- Model / Reference
- PS10223 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 05055273215694 FDA UDI
- FDA Product Code
- JJY FDA UDI
- GMDN Term
- Multiple clinical chemistry protein IVD, control FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 862.1660 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Multiple clinical chemistry protein IVD, control
Specific Protein Control - Level 3 (sp Control 3) by Randox Laboratories, Ltd. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Multiple clinical chemistry protein IVD, control.
- InteliQ — Bio-Rad Laboratories · Class I
- Lyphochek — Bio-Rad Laboratories · Class I
- InteliQ — Bio-Rad Laboratories · Class I
- Liquichek — Bio-Rad Laboratories · Class I
- Liquichek — Bio-Rad Laboratories · Class I
- InteliQ — Bio-Rad Laboratories · Class I
- Yumizen C1200 Level 1 Protein Control — Horiba Abx · Class I
- Liquichek — Bio-Rad Laboratories · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Randox Laboratories, Ltd.
Sources (1)
- FDA UDI 5a58b2ff-5764-479f-a410-1e2cb1d0e0c2 32 fields · synced May 31, 2026